Moderna Therapeutics

article

Who will receive COVID-19 vaccines first?

12 October 2020 | By Hannah Balfour (European Pharmaceutical Review)

EPR’s Hannah Balfour discusses some of the proposed COVID-19 vaccine distribution plans and how medicinal nationalism and supply deals could prevent “fair and equitable access” to COVID-19 vaccines.

news

Biopharma pledges to uphold scientific integrity in COVID-19 vaccine development

9 September 2020 | By Hannah Balfour (European Pharmaceutical Review)

Nine biopharma CEOs pledged to make the integrity of the scientific process and sufficient supply priorities in the development of COVID-19 vaccines.

news

Experimental COVID-19 vaccine mRNA-1273 is safe and elicits response

15 July 2020 | By Hannah Balfour (European Pharmaceutical Review)

Interim analysis of the Phase I trial data from 45 patients indicates mRNA-1273 can drive the production of antibodies targeting the SARS-CoV-2 spike protein.

article

COVID-19 and big pharma: what are 15 leading companies doing to develop a coronavirus vaccine?

10 April 2020 | By Victoria Rees (European Pharmaceutical Review)

A new report has revealed the vaccine R&D efforts of 15 of the leading pharmaceutical companies to combat the COVID-19 coronavirus.